Clinical Trial Update: Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 3g vs 2g mycophenolate mofetil (MMF) with tacrolimus in renal allograft fibrosis progression; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure
• Kidney Transplantation

Drugs mentioned

• MMF (mycophenolate mofetil) (mycophenolate mofetil)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Clinical Hospital Merkur | Conditions: Kidney Transplantation, Kidney Failure | Phase 4 | Status: COMPLETED